Aclarion (Aclarion) Price-to-Operating-Cash-Flow : (As of May. 29, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Aclarion Price-to-Operating-Cash-Flow?

As of today (2024-05-29), Aclarion's share price is $0.303. Aclarion's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-11.28. Hence, Aclarion's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Aclarion's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 5 years, Aclarion's highest Price-to-Operating-Cash-Flow Ratio was 13.82. The lowest was 0.00. And the median was 0.00.

ACON's Price-to-Operating-Cash-Flow is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 12.855
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Aclarion's Cash Flow from Operations per share for the three months ended in Mar. 2024 was $-6.59. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-11.28.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -17.90% per year.

During the past 5 years, Aclarion's highest 3-Year average Operating Cash Flow per Share Growth Rate was -11.70% per year. The lowest was -17.90% per year. And the median was -14.80% per year.

Aclarion Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Aclarion's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aclarion Price-to-Operating-Cash-Flow Chart

Aclarion Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Aclarion Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Aclarion's Price-to-Operating-Cash-Flow

For the Health Information Services subindustry, Aclarion's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aclarion's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aclarion's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aclarion's Price-to-Operating-Cash-Flow falls into.

Aclarion Price-to-Operating-Cash-Flow Calculation

Aclarion's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.303	/	-11.284
	=

Aclarion's Share Price of today is $0.303.
Aclarion's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.28.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Aclarion Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Aclarion's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Aclarion (Aclarion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aclarion Inc (NAS:ACON) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

8181 Arista Place, Suite 300, Broomfield, CO, USA, 80021

Website

http://www.aclarion.com

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Executives

John Paul Lorbiecki	officer: Chief Financial Officer	238 CHEYENNE DRIVE, LAFAYETTE CO 80026
Brent Ness	director, officer: Chief Executive Officer	951 MARINERS ISLAND BLVD., SUITE 300, SAN MATEO CA 94404
Ryan Bond	officer: Chief Strategy Officer	951 MARINERS ISLAND BLVD., SUITE 300, SAN MATEO CA 94404
Stephen Deitsch	director	1600 BROADWAY, SUITE 700, DENVER CO 80202
William Wesemann	director	130 MONTALVO ROAD, REDWOOD CITY CA 94062
Jeffrey John Thramann	director, officer: Executive Chairman	8580 STRAWBERRY LANE, NIWOT CO 80503
Michael W Dirks	10 percent owner	811 EAST 30TH AVE, HUTCHINSON KS 67502
Nuvasive Inc	10 percent owner	7475 LUSK BLVD, SAN DIEGO CA 92121
Sc Capital 1 Llc	10 percent owner	1 COMPOUND DRIVE, HUTCHINSON KS 67502
Scott Breidbart	director	951 MARINERS ISLAND BLVD, SUITE 300, SAN MATEO CA 94404
Amanda Mae Sequira	director	951 MARINERS ISLAND BLVD., SUITE 300, SAN MATEO CA 94404
David K Neal	director	C/O ACLARION, INC., 951 MARINERS ISLAND BLVD, SUITE 300, SAN MATEO CA 94404